100 related articles for article (PubMed ID: 12642467)
1. Characterization of substrate binding to cytochrome P450 1A1 using molecular modeling and kinetic analyses: case of residue 382.
Liu J; Ericksen SS; Besspiata D; Fisher CW; Szklarz GD
Drug Metab Dispos; 2003 Apr; 31(4):412-20. PubMed ID: 12642467
[TBL] [Abstract][Full Text] [Related]
2. The effect of reciprocal active site mutations in human cytochromes P450 1A1 and 1A2 on alkoxyresorufin metabolism.
Liu J; Ericksen SS; Sivaneri M; Besspiata D; Fisher CW; Szklarz GD
Arch Biochem Biophys; 2004 Apr; 424(1):33-43. PubMed ID: 15019834
[TBL] [Abstract][Full Text] [Related]
3. Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants.
Tu Y; Deshmukh R; Sivaneri M; Szklarz GD
Drug Metab Dispos; 2008 Nov; 36(11):2371-80. PubMed ID: 18703643
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling of cytochrome P450 1A1: enzyme-substrate interactions and substrate binding affinities.
Szklarz GD; Paulsen MD
J Biomol Struct Dyn; 2002 Oct; 20(2):155-62. PubMed ID: 12354067
[TBL] [Abstract][Full Text] [Related]
5. Probing the active site of cytochrome P450 2B1: metabolism of 7-alkoxycoumarins by the wild type and five site-directed mutants.
Kobayashi Y; Fang X; Szklarz GD; Halpert JR
Biochemistry; 1998 May; 37(19):6679-88. PubMed ID: 9578551
[TBL] [Abstract][Full Text] [Related]
6. Escherichia coli expression of site-directed mutants of cytochrome P450 2B1 from six substrate recognition sites: substrate specificity and inhibitor selectivity studies.
He YQ; He YA; Halpert JR
Chem Res Toxicol; 1995 Jun; 8(4):574-9. PubMed ID: 7548737
[TBL] [Abstract][Full Text] [Related]
7. Role of residue 480 in substrate specificity of cytochrome P450 2B5 and 2B11.
Liu J; He YA; Halpert JR
Arch Biochem Biophys; 1996 Mar; 327(1):167-73. PubMed ID: 8615687
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Ala62Pro polymorphic variant of human cytochrome P450 1A1 using recombinant protein expression.
Lee SH; Kang S; Dong MS; Park JD; Park J; Rhee S; Ryu DY
Toxicol Appl Pharmacol; 2015 Jun; 285(3):159-69. PubMed ID: 25902338
[TBL] [Abstract][Full Text] [Related]
9. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
Chun YJ; Shimada T; Guengerich FP
Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic analysis of cDNA-expressed human CYP1A1, CYP1A2, and CYP1B1 with 7-ethoxyresorufin as substrate.
Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():85-90. PubMed ID: 16719376
[TBL] [Abstract][Full Text] [Related]
11. Molecular Cloning, Tissue Distribution, and Functional Characterization of Marmoset Cytochrome P450 1A1, 1A2, and 1B1.
Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2016 Jan; 44(1):8-15. PubMed ID: 26502772
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P450 2B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P450 2B4.
Szklarz GD; He YQ; Kedzie KM; Halpert JR; Burnett VL
Arch Biochem Biophys; 1996 Mar; 327(2):308-18. PubMed ID: 8619620
[TBL] [Abstract][Full Text] [Related]
13. Interconversion of the androstenedione hydroxylase specificities of cytochromes P450 2B4 and 2B5 upon simultaneous site-directed mutagenesis of four key substrate recognition residues.
He YQ; Szklarz GD; Halpert JR
Arch Biochem Biophys; 1996 Nov; 335(1):152-60. PubMed ID: 8914846
[TBL] [Abstract][Full Text] [Related]
14. Comparative homology modeling of human cytochrome P4501A1 (CYP1A1) and confirmation of residues involved in 7-ethoxyresorufin O-deethylation by site-directed mutagenesis and enzyme kinetic analysis.
Lewis BC; Mackenzie PI; Miners JO
Arch Biochem Biophys; 2007 Dec; 468(1):58-69. PubMed ID: 17959138
[TBL] [Abstract][Full Text] [Related]
15. Molecular recognition in (+)-alpha-pinene oxidation by cytochrome P450cam.
Bell SG; Chen X; Sowden RJ; Xu F; Williams JN; Wong LL; Rao Z
J Am Chem Soc; 2003 Jan; 125(3):705-14. PubMed ID: 12526670
[TBL] [Abstract][Full Text] [Related]
16. Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6.
Hayhurst GP; Harlow J; Chowdry J; Gross E; Hilton E; Lennard MS; Tucker GT; Ellis SW
Biochem J; 2001 Apr; 355(Pt 2):373-9. PubMed ID: 11284724
[TBL] [Abstract][Full Text] [Related]
17. Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling.
Spatzenegger M; Liu H; Wang Q; Debarber A; Koop DR; Halpert JR
J Pharmacol Exp Ther; 2003 Jan; 304(1):477-87. PubMed ID: 12490624
[TBL] [Abstract][Full Text] [Related]
18. Interaction of polycyclic aromatic hydrocarbons with human cytochrome P450 1A1: a CO flash photolysis study.
Koley AP; Buters JT; Robinson RC; Markowitz A; Friedman FK
Arch Biochem Biophys; 1996 Dec; 336(2):261-7. PubMed ID: 8954573
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by naturally occurring coumarins.
Cai Y; Baer-Dubowska W; Ashwood-Smith MJ; Ceska O; Tachibana S; DiGiovanni J
Chem Res Toxicol; 1996 Jun; 9(4):729-36. PubMed ID: 8831817
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of 7-methoxyresorufin O-demethylation activity of human cytochrome P450 1A2 by molecular breeding.
Kim D; Guengerich FP
Arch Biochem Biophys; 2004 Dec; 432(1):102-8. PubMed ID: 15519301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
